No abstract available
MeSH terms
-
Cost-Benefit Analysis
-
Hepatitis A / prevention & control*
-
Hepatitis A Vaccines
-
Hepatovirus / immunology
-
Humans
-
Travel*
-
Vaccines, Inactivated
-
Viral Hepatitis Vaccines / economics*
Substances
-
Hepatitis A Vaccines
-
Vaccines, Inactivated
-
Viral Hepatitis Vaccines